|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date / Period | Status |
|---|---|---|
| Fibromyalgia | 04-Feb-2014 | active |
| Anemia | 17-Nov-2013 | active |
| Acute bronchitis | 04-May-2025 - 24-May-2025 | inactive |
| Acute bronchitis | 07-Apr-2024 - 14-Apr-2024 | inactive |
| Miscarriage in first trimester | 19-Jan-2020 - 02-Feb-2020 | inactive |
| Blighted ovum | 19-Jan-2020 - 02-Feb-2020 | inactive |
| Miscarriage in first trimester | 03-Feb-2019 - 22-Feb-2019 | inactive |
| Complete miscarriage | 03-Feb-2019 - 22-Feb-2019 | inactive |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Fentanyl 25 microgram/hour prolonged-release transdermal patch | 2025-04-27 | - | 25 micrograms per hour, apply one patch every 72 hours | - |
| Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet | 2025-04-27 | - | 1 tablet (300 mg/5 mg) every 4 to 6 hours as needed for pain | - |
| Oxycodone hydrochloride 10 mg prolonged-release oral tablet | 2025-04-27 | - | 1 tablet (10 mg) every 12 hours | - |
| Acetaminophen 325 mg and oxycodone hydrochloride 10 mg oral tablet | 2025-04-27 | - | 1 tablet (325 mg/10 mg) by mouth every 6 hours as needed for pain | - |
| Hydrocodone bitartrate 10 mg and ibuprofen 200 mg oral tablet | 2025-04-27 | - | 1 tablet (10 mg/200 mg) every 4 to 6 hours as needed for pain | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 19-Jan-2025 |
| Live attenuated Human alphaherpesvirus 3 only vaccine product | 19-Jan-2025 |
| Influenza virus antigen only vaccine product | 19-Jan-2025 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 31-Mar-2024 | - |
| Medication reconciliation | 31-Mar-2024 | - |
| Assessment of health and social care needs | 31-Mar-2024 | - |
| Assessment of anxiety | 31-Mar-2024 | - |
| Instrumental delivery | 17-Jan-2016 | Normal pregnancy (finding) |
Allergies and Intolerances
| No known allergies or intolerances |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Respiratory therapy | 04-May-2025 | - |
| Therapy | 17-Mar-2014 | - |
| Diabetes self management plan | 17-Nov-2013 | Prediabetes (finding) |
|
Vital Signs
| Vital Signs | 2025-04-27 | 2025-01-19 |
|---|---|---|
| Body Height | 163.2 cm | 163.2 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 1 {score} | 3 {score} |
| Body Weight | 80.4 kg | 80.4 kg |
| Body mass index (BMI) [Ratio] | 30.2 kg/m2 | 30.2 kg/m2 |
| Heart rate | 67 /min | 71 /min |
| Respiratory rate | 14 /min | 14 /min |
| Blood pressure panel with all children optional | 75 mm[Hg] | 78 mm[Hg] |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 27-APR-2025 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.2 H | 4.0 - 5.6 | % |
| Glucose [Mass/volume] in Blood | 64.4 L | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 17.8 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 1.0 | 0.5 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.5 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 139.2 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.8 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 103.4 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 27.1 | 22 - 32 | mmol/L |
Device Use
| Device | Date (since) |
|---|---|
| Blood glucose meter (physical object) | 17-Nov-2013 |